Anne Deucher, MD, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentLaboratory Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tan CA, Rabideau M, Blevins A, Westbrook MJ, Ekstein T, Nykamp K, Deucher A, Harper A, Demmer L. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review. Am J Med Genet A. 2016 Jun; 170(6):1580-4. PMID: 26955893.
      View in: PubMed
    2. Deucher A, Qi Z, Yu J, George TI, Etzell JE. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia. Am J Clin Pathol. 2015 Apr; 143(4):547-57. PMID: 25780007.
      View in: PubMed
    3. Geng H, Hurtz C, Lenz KB, Chen Z, Baumjohann D, Thompson S, Goloviznina NA, Chen WY, Huan J, LaTocha D, Ballabio E, Xiao G, Lee JW, Deucher A, Qi Z, Park E, Huang C, Nahar R, Kweon SM, Shojaee S, Chan LN, Yu J, Kornblau SM, Bijl JJ, Ye BH, Mark Ansel K, Paietta E, Melnick A, Hunger SP, Kurre P, Tyner JW, Loh ML, Roeder RG, Druker BJ, Burger JA, Milne TA, Chang BH, Müschen M. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. Cancer Cell. 2015 Mar 09; 27(3):409-25. PMID: 25759025; PMCID: PMC4618684.
    4. Wool GD, Deucher A. Bone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. Am J Clin Pathol. 2015 Feb; 143(2):201-13; quiz 306. PMID: 25596246.
      View in: PubMed
    5. Deucher A, Chiang T, Schrijver I. Rare sequence variation in the genome flanking a short tandem repeat locus can lead to a question of "nonmaternity". J Mol Diagn. 2010 May; 12(3):384-9. PMID: 20203001; PMCID: PMC2860477.
    6. Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R, Balasubramanian S. Regulation of involucrin gene expression. J Invest Dermatol. 2004 Jul; 123(1):13-22. PMID: 15191537.
      View in: PubMed
    7. Sturniolo MT, Dashti SR, Deucher A, Rorke EA, Broome AM, Chandraratna RA, Keepers T, Eckert RL. A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem. 2003 Nov 28; 278(48):48066-73. PMID: 12928434.
      View in: PubMed
    8. Eckert RL, Efimova T, Dashti SR, Balasubramanian S, Deucher A, Crish JF, Sturniolo M, Bone F. Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. J Investig Dermatol Symp Proc. 2002 Dec; 7(1):36-40. PMID: 12518790.
      View in: PubMed
    9. Efimova T, Deucher A, Kuroki T, Ohba M, Eckert RL. Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha. J Biol Chem. 2002 Aug 30; 277(35):31753-60. PMID: 12080077.
      View in: PubMed
    10. Deucher A, Efimova T, Eckert RL. Calcium-dependent involucrin expression is inversely regulated by protein kinase C (PKC)alpha and PKCdelta. J Biol Chem. 2002 May 10; 277(19):17032-40. PMID: 11864971.
      View in: PubMed
    11. Deucher A, Nagpal S, Chandraratna RA, Di Sepio D, Robinson NA, Dashti SR, Eckert RL. The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol. 2000 Dec; 17(6):1195-203. PMID: 11078805.
      View in: PubMed
    12. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S. Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res. 2000 Aug; 6(8):3249-59. PMID: 10955811.
      View in: PubMed
    13. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):14811-5. PMID: 9843971; PMCID: PMC24531.
    14. Singer SS, Henkels K, Deucher A, Barker M, Singer J, Trulzsch DV. Growth hormone and aging change rat liver fatty acid binding protein levels. J Am Coll Nutr. 1996 Apr; 15(2):169-74. PMID: 8778148.
      View in: PubMed
    Back to TOP